Pertussis vaccines.
Journal
Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
pubmed:
27
1
2022
medline:
26
4
2022
entrez:
26
1
2022
Statut:
ppublish
Résumé
Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination. Pertussis cases and deaths in children are at a record low number. More complete use of adolescent/adult vaccine can further reduce morbidity and mortality. Considerable progress in the control of pertussis has occurred over the last 75 years. The universal use of Tdap vaccines in all pregnant women will prevent virtually all pertussis deaths.
Identifiants
pubmed: 35081553
doi: 10.1097/MOP.0000000000001108
pii: 00008480-202204000-00004
doi:
Substances chimiques
Diphtheria-Tetanus-acellular Pertussis Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-131Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326–382.
Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin and Cherry's textbook of pediatric infectious diseases. 8th ed., Vol. 1. Philadelphia, PA: Elsevier; 2019. P. 1159−77.
Guiso N, Meade BD, Wirsing von König CH. Pertussis vaccines: the first hundred years. Vaccine 2020; 38:1271–1276.
Bordet J, Gengou O. LE microbe de la coqueluche. Ann Inst Pasteur (Paris) 1906; 20:48–68.
Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984; 14:1–78.
Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the task force on pertussis and pertussis immunization − 1988. Pediatrics 1988; 81:939–984.
Cherry JD. The 112-year odyssey of pertussis and pertussis vaccines − mistakes made and implications for the future. J Pediatric Infect Dis Soc 2019; 8:334–341.
Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650–660.
Baraff LJ, Manclark CR, Cherry JD, et al. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J 1989; 8:502–507.
Cherry JD. Pertussis and the vaccine controversy. In: Root RK, Griffiss JM, Warren KS, et al. editors. Immunization. New York, NY: Churchill Livingstone; 1989. p. 47−63.
Harcourt Brace Jovanovich, Coulter HL, Fisher BL. DPT: a shot in the dark. 1985.
Cherry JD. Pertussis vaccine encephalopathy: it is time to recognize it as the myth that it is. JAMA 1990; 263:1679–1680.
Simondon F, Preziosi MP, Yam A, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997; 15:1606–1612.
Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996; 334:341–348.
Olin P, Rasmussen F, Gustafsson L, et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997; 350:1569–1577.
Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998; 101 (Pt 1):1–11.
Liese JG, Meschievitz CK, Harzer E, et al. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J 1997; 16:1038–1044.
Schmitt HJ, von König CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996; 275:37–41.
Cherry JD, Heininger U, Stehr K, Christenson P. The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics 1998; 102 (4 Pt 1):909–912.
Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis 1979; 1:401–412.
Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis 1984; 3:467–486.
Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1984; 1:122–126.
Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464–471.
Schmitt-Grohé S, Cherry JD, Heininger U, et al. Pertussis in German adults. Clin Infect Dis 1995; 21:860–866.
Deville JG, Cherry JD, Christenson PD, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995; 21:639–642.
Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211–1219.
Cherry JD. The role of Bordetella pertussis infections in adults in the epidemiology of pertussis. Dev Biol Stand 1997; 89:181–186.
Vincent JM, Cherry JD, Nauschuetz WF, et al. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 2000; 30:534–539.
Jackson LA, Cherry JD, Wang SP, Grayston JT. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis 2000; 31:3–6.
Hodder SL, Cherry JD, Mortimer EA Jr, et al. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 2000; 31:7–14.
Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995−1996. J Infect Dis 2001; 183:1353–1359.
Cherry JD. Adult pertussis in the pre and postvaccine eras: lifelong vaccine-induced immunity? Expert Rev Vaccines 2014; 13:1073–1080.
Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985–989.
Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238–242.
Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293–299.
Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384:1521–1528.
Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012; 308:454–456.